feed,title,long_url,short_url
MedRxiv,Predicted Symptomatic Effectiveness of Pfizer-BioNTech BNT162b2 Vaccine Against Omicron Variant of SARS-CoV-2,https://medrxiv.org/cgi/content/short/2021.12.09.21267556v1?rss=1,https://j.mp/3DMGFcr
